FindTrial
Sign In

A medical records based study for prevalence of hyperthyroidism with hypercalcemia and clinical observation after vitamin D3 treatment

Prevalence of hyperthyroidism with hypercalcemia in XinDu district and the efficacy of vitamin D3 treatment on these patient in a retrospective study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047870
Enrollment
Unknown
Registered
2021-06-27
Start date
2021-06-16
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperthyroidism with hypercalcemia

Interventions

case series:No

Sponsors

The First Affiliated Hospital of Chengdu Medical College
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria were age between 18 and 70 y, a first-time diagnose of GD, hyperthyroidism combined with hypercalcemia at first visit, and initiated or planned ATD as the treatment of choice.

Exclusion criteria

Exclusion criteria: Exclusion criteria were: (1) non-hyperthyroidism disease and previous hyperthyroidism; (2) serum calcium < 2.52mmol/L and impaired kidney function (estimated glomerular filtration rate [eGFR] <45mL/min) (3) tumor or presence of malignant disease; (4) hyperparathyroidism disease; (5) hyperthyroidism crisis; (6) diabetes insipidus ; (7) pregnant; (8) mental illness or inability to cooperate.

Design outcomes

Primary

MeasureTime frame
Vitamin D;—

Countries

China

Contacts

Public ContactMei Xi
messi0802@163.com+86 15828386662

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026